Publication Type: Article
Journal Name: Health Affairs
Full Citation: Kesselheim, A., Darby, D., Studdert, D., Glynn, R., Levin, R., Avorn, J. "False Claims Act Prosecution Did Not Deter Off-Label Drug Use in the Case of Neurontin." Health Affairs, Dec 2011, 30(12): 2318-2327.
Project: Sources of Transformative Innovation in Medication Development
People: Aaron Kesselheim